NHS Evidence - Neurological conditions - Child development following in utero exposure: Levetiracetam vs sodium valproate

Links shared publicly online about this topic.

540
total visits

NHS Evidence - Neurological conditions - Child development following in utero exposure: Levetiracetam vs sodium valproate

Bibliographic details: Shallcross R, Bromley RL, Irwin B, Bonnett LJ, Morrow J, Baker GA. (2011) Child development following in utero exposure: Levetiracetam vs sodium valproate. Neurology 76(4):383-389 Objective: Children born to women with epilepsy (WWE), exposed in utero to levetiracetam (LEV, n = 51), were assessed for early cognitive development and compared to children exposed to sodium valproate in utero (VPA, n = 44) and a group of children representative of the general population (n = 9

View full resource at library.nhs.uk

Tags: Neurology, Seizure Medication, Mineral, Sodium, Children's Health, Women's Health, Keppra, Epilepsy Medication